FDA Seizes Illegal Medicines Worth ₹80,000 From Bhiwandi Eye Hospital

Mumbai: The Maharashtra Food and Drug Administration (FDA) seized illegal stock of medicines worth Rs80,000 from Aarav Eye Hospital in Bhiwandi on February 9 after a tip-off. This is the second such raid this year.

Earlier this month, the FDA busted a counterfeit medicine racket in Nagpur and seized 21,600 tablets of ciprofloxacin procured through a government contract. Samples of this drug were taken in March last year  but its results that it lacked any therapeutic value came in December.

In the present case, the eye hospital, owned by Dr Ashwin Bafna, didn’t have the licence to stock medicines. The hospital was established in 2005 and opened its second branch in Mira Road in 2017. The Bhiwandi branch opened in 2021.

A senior FDA official said that the pharmacist, Mohammad Ansari, didn’t have the licence required under the provisions of Drugs and Cosmetics Act, 1940 and Rules thereunder. Ansari initially told officials that he has the Pharmacists Registration Certificate issued by the Maharashtra Pharmacy Council but could not produce it; he later admitted not having any qualification as a pharmacist, the FDA official said. He added that the medicines seized can be sold only on the advice of a physician.

The official said, “Samples were drawn from the available stock and sale bills issued on and before February 9 were taken into custody.”

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?